Byoung-Ryun Kim Selected Research

Cytokines

1/2017

Diagnostic Significance of Measuring Vascular Endothelial Growth Factor for the Differentiation between Malignant and Tuberculous Pleural Effusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Byoung-Ryun Kim Research Topics

Disease

9	Lung Neoplasms (Lung Cancer) 01/2017 - 10/2011
5	Neoplasms (Cancer) 01/2017 - 10/2011
3	Malignant Pleural Effusion 01/2017 - 02/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2015 - 05/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 05/2015 - 07/2013
2	Pleural Effusion (Pleural Effusions) 01/2017 - 02/2012
2	Malignant Mesothelioma 05/2015 - 10/2014
1	Carcinoma (Carcinomatosis) 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Carcinogenesis 01/2017
1	Mesothelioma 05/2015

Drug/Important Bio-Agent (IBA)

4	Simvastatin (Zocor)FDA LinkGeneric 10/2014 - 10/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 07/2013
2	Tumor Biomarkers (Tumor Markers)IBA 01/2017 - 02/2012
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2012
2	Sulindac (Copal)FDA LinkGeneric 08/2016 - 07/2013
2	Sirtuin 1IBA 08/2016 - 05/2015
2	Folic Acid AntagonistsIBA 05/2015 - 10/2014
2	Pemetrexed (MTA)FDA Link 05/2015 - 10/2014
2	Small Interfering RNA (siRNA)IBA 05/2015 - 07/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2013 - 10/2011
2	SurvivinIBA 02/2012 - 10/2011
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 01/2017
1	RNA Splicing FactorsIBA 01/2017
1	Arginine (L-Arginine)FDA Link 01/2017
1	EnzymesIBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	Serine (L-Serine)FDA Link 01/2017
1	CytokinesIBA 01/2017
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Celecoxib (Celebrex)FDA Link 08/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2016
1	ResveratrolIBA 05/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 10/2014
1	Gefitinib (Iressa)FDA Link 05/2014
1	ErbB Receptors (EGF Receptor)IBA 05/2014
1	Tyrosine Kinase InhibitorsIBA 05/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2014
1	Docetaxel (Taxotere)FDA Link 07/2013
1	CaspasesIBA 07/2013
1	C-Reactive ProteinIBA 03/2013
1	antigen CYFRA21.1IBA 02/2012

Therapy/Procedure

1	Chemoprevention 07/2013
1	Drug Therapy (Chemotherapy) 02/2012